GIPLOTCSurgical & Medical Instruments & ApparatusFiscal year ends September 30

Global Innovative Platforms Inc.

Financials through Q1 FY2026, quarter ended Dec 31, 2025Last filing: 10-Q on Aug 14, 2026

$0.50+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Global Innovative Platforms Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-09-30	FY 2024 2024-09-30	FY 2023 2023-09-30	FY 2022 2022-09-30	FY 2021 2021-09-30
Revenue	0	0	0	0	0
Research & Development	0.38	0.02	–	–	–
General & Administrative	0.34	0.11	0.28	0.05	0.07
Advertising Expenses	0	0	0	0	0
Operating Expenses	0.72	0.14	0.28	0.05	0.07
Operating Income	-0.72	-0.14	-0.28	-0.05	-0.07
Other Non-Operating Income	–	0	0	0	0
Pretax Income	-0.72	-0.14	-0.28	-0.05	-0.07
Income Tax Expense	–	0	0	0	0
Net Income incl. Noncontrolling Interests	0.72	-0.14	–	-0.05	-0.07
Net Income	-0.72	-0.14	-0.28	-0.05	–
Net Income to Common	–	–	–	-0.05	-0.07
EPS (Basic)(per share)	-0.02	-0.0050	-0.46	-0.08	-0.12
EPS (Diluted)(per share)	-0.02	-0.0050	-0.46	-0.08	-0.12
Shares Outstanding (Basic, Weighted)(shares)	39	27	0.62	0.62	0.62
Shares Outstanding (Diluted, Weighted)(shares)	39	27	0.62	0.62	0.62

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -2157.4%
Net margin: -2157.4%
Return on equity, FY2025: -929.6%

Financial strength

Current ratio: 34.73
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 3134.8%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –